Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
In vivo bradykinin B2 receptor activation reduces renal fibrosis
Joost P. Schanstra, … , Jean-Pierre Girolami, Jean-Loup Bascands
Joost P. Schanstra, … , Jean-Pierre Girolami, Jean-Loup Bascands
Published August 1, 2002
Citation Information: J Clin Invest. 2002;110(3):371-379. https://doi.org/10.1172/JCI15493.
View: Text | PDF
Article Genetics

In vivo bradykinin B2 receptor activation reduces renal fibrosis

  • Text
  • PDF
Abstract

Research Article

Authors

Joost P. Schanstra, Eric Neau, Pascale Drogoz, Miguel A. Arevalo Gomez, José Miguel Lopez Novoa, Denis Calise, Christiane Pecher, Michael Bader, Jean-Pierre Girolami, Jean-Loup Bascands

×

Figure 1

Options: View larger image (or click on image) Download as PowerPoint
Quantitative analysis of UUO-induced renal interstitial collagen express...
Quantitative analysis of UUO-induced renal interstitial collagen expression in B2–/– knockout mice, kallikrein transgenic rats, and B2 receptor antagonist–treated wild-type mice. (a) Collagen expression in obstructed kidneys from B2+/+ and B2–/– mice after different periods of ureteral obstruction (3 hours to 14 days). Data are expressed as the mean ± SD percentage of the interstitial area stained; n = 10; *P < 0.05 compared with respective B2+/+ (same time of obstruction). (b) Representative photographs of Sirius red–stained renal sections of 5 day–obstructed and sham-operated B2+/+ and B2–/– mice. Original magnification ×400. (c) Collagen expression in kidneys from 5 day–obstructed and sham-operated kallikrein transgenic and control (Sprague Dawley) rats. One group was treated with HOE-140. n = 5 per group. *P < 0.05 compared with sham-operated rats; ‡P < 0.05 compared with UUO kallikrein transgenic rats without HOE-140. (d) Collagen expression in kidneys from 5 day–obstructed B2+/+ mice treated with saline only or with saline containing HOE-140 at 500 μg/kg/d; n = 10 per group. Data expressed as the mean ± SD percentage of the interstitial area stained; *P < 0.05 compared to without HOE-140.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts